\-\ Texto\\:\\ \ \(0\)\
\-\ elevated\\ insulin\\ and\\ c\\-peptide\\ levels\\.\\ low\\ glucose\\ levels\\.\ \(0\)\
\-\ excision\\ and\\ monitoring\\ for\\ metastases\\.\ \(0\)\
\-\ axial\\ ct\\ with\\ iv\\ contrast\\ demonstrates\\ a\\ hypodense\\ mass\\ with\\ circumscribed\\ enhancement\\ in\\ the\\ body\\ of\\ the\\ pancreas\\.\ \(0\)\
\-\ insulinoma\\.\\ although\\ the\\ octreotide\\ scan\\ was\\ performed\\ and\\ was\\ negative\\,\\ histologic\\ analysis\\ of\\ the\\ surgical\\ specimen\\ revealed\\ an\\ insulinoma\\.\ \(0\)\
\-\ islet\\ cell\\ tumors\\ like\\ insulinoma\ \(0\)\
\-\ pancreatic\\ adenocarcinoma\\,\\ unlikely\ \(0\)\
\-\ macrocystic\\ adenoma\\,\\ unlikely\ \(0\)\
\-\ 25\\ yo\\ male\\ active\\ duty\\ soldier\\ in\\ the\\ field\\ with\\ recurrent\\ bouts\\ of\\ hypoglycemia\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ insulinoma\\:\\ 0\\.25433225334820225\ \(0\)\
\-\ c\\-peptide\\:\\ 0\\.10371198145842939\ \(0\)\
\-\ unlikely\\:\\ 0\\.09577850107301761\ \(0\)\
\-\ levels\\:\\ 0\\.08299415042992854\ \(0\)\
\-\ octreotide\\:\\ 0\\.07924796332101955\ \(0\)\
\-\ macrocystic\\:\\ 0\\.07786228054859151\ \(0\)\
\-\ bouts\\:\\ 0\\.07786228054859151\ \(0\)\
\-\ hypoglycemia\\:\\ 0\\.07786228054859151\ \(0\)\
\-\ insulin\\:\\ 0\\.07550144883727208\ \(0\)\
\-\ islet\\:\\ 0\\.07266424816883811\ \(0\)\
\-\ histologic\\:\\ 0\\.06369789461534521\ \(0\)\
\-\ soldier\\:\\ 0\\.06331213199389826\ \(0\)\
\-\ specimen\\:\\ 0\\.060313399645324256\ \(0\)\
\-\ monitoring\\:\\ 0\\.05554322190287527\ \(0\)\
\-\ glucose\\:\\ 0\\.05372968449314281\ \(0\)\
\-\ hypodense\\:\\ 0\\.05356280643441391\ \(0\)\
\-\ duty\\:\\ 0\\.05245658349737537\ \(0\)\
\-\ field\\:\\ 0\\.05158472500144922\ \(0\)\
\-\ pancreas\\:\\ 0\\.051445496087955074\ \(0\)\
\-\ analysis\\:\\ 0\\.051171885944846056\ \(0\)\
\-\ pancreatic\\:\\ 0\\.0491857580674925\ \(0\)\
\-\ like\\:\\ 0\\.04653771787770383\ \(0\)\
\-\ circumscribed\\:\\ 0\\.04468515984884204\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.04343005228897928\ \(0\)\
\-\ metastases\\:\\ 0\\.042949793529917464\ \(0\)\
\-\ recurrent\\:\\ 0\\.042423909072059736\ \(0\)\
\-\ adenoma\\:\\ 0\\.041982286491835434\ \(0\)\
\-\ excision\\:\\ 0\\.04126177325370933\ \(0\)\
\-\ 25\\:\\ 0\\.040637955979494975\ \(0\)\
\-\ active\\:\\ 0\\.03838304516523389\ \(0\)\
\-\ tumors\\:\\ 0\\.0377613689137706\ \(0\)\
\-\ iv\\:\\ 0\\.03668735220542463\ \(0\)\
\-\ elevated\\:\\ 0\\.03410960425128309\ \(0\)\
\-\ although\\:\\ 0\\.03395210918325416\ \(0\)\
\-\ body\\:\\ 0\\.032650161325753935\ \(0\)\
\-\ revealed\\:\\ 0\\.03226439870430698\ \(0\)\
\-\ yo\\:\\ 0\\.030251194391797197\ \(0\)\
\-\ negative\\:\\ 0\\.03002494307499852\ \(0\)\
\-\ axial\\:\\ 0\\.028691664424327898\ \(0\)\
\-\ scan\\:\\ 0\\.028144370122740923\ \(0\)\
\-\ performed\\:\\ 0\\.028030333308556695\ \(0\)\
\-\ low\\:\\ 0\\.027954918269016464\ \(0\)\
\-\ cell\\:\\ 0\\.027155773077429248\ \(0\)\
\-\ enhancement\\:\\ 0\\.02694692666027101\ \(0\)\
\-\ was\\:\\ 0\\.023253588757969103\ \(0\)\
\-\ contrast\\:\\ 0\\.02250324337421065\ \(0\)\
\-\ demonstrates\\:\\ 0\\.02196024943121395\ \(0\)\
\-\ surgical\\:\\ 0\\.02113202082648769\ \(0\)\
\-\ male\\:\\ 0\\.018178888681029095\ \(0\)\
\-\ ct\\:\\ 0\\.014062395922259328\ \(0\)\
\-\ mass\\:\\ 0\\.013981894199383112\ \(0\)\
\-\ an\\:\\ 0\\.01390193957982035\ \(0\)\
\-\ in\\:\\ 0\\.009915228944476587\ \(0\)\
\-\ \\,\\:\\ 0\\.009554472900610143\ \(0\)\
\-\ for\\:\\ 0\\.008577742925208413\ \(0\)\
\-\ the\\:\\ 0\\.008132310864919164\ \(0\)\
\-\ and\\:\\ 0\\.006353259025843004\ \(0\)\
\-\ a\\:\\ 0\\.004665880021395309\ \(0\)\
\-\ with\\:\\ 0\\.004129559156113755\ \(0\)\
\-\ of\\:\\ 0\\.00411189885169371\ \(0\)\
\-\ \\.\\:\\ 0\\.002923491208016752\ \(0\)\
